Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-030767
Filing Date
2021-07-29
Accepted
2021-07-29 21:01:55
Documents
2
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2183
2 EX-24 DOCUMENT attachment1.htm EX-24 4282
  Complete submission text file 0000899243-21-030767.txt   7829
Mailing Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 (617) 949-4360
Omega Therapeutics, Inc. (Issuer) CIK: 0001850838 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O OMEGA THERAPEUTICS, INC. 20 ACORN PARK D CAMBRIDGE MA 02140
Business Address
Jaenisch Rudolf (Reporting) CIK: 0001875241 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40657 | Film No.: 211129582